Tech Tuesday – Mei He
In this week's Tech Tuesday for WCJB TV20, UF Innovate's Melanie Morón interviews Mei He, associate professor in the UF College of Pharmacy. Her research focuses on advancing the delivery of drugs to the human body.
By utilizing naturally-derived materials, the drug delivery process is more efficient and the drug's efficacy is maximized.
President’s Office Announces $10.2 Million for Fourth Round of Strategic Funding Awardees
The UF President's Office recently announced a fourth round of strategic funding to grow UF's research capabilities in critical areas of AI, space exploration, healthcare, and more.
Combination of Two Common Compounds Improves COVID Survival in Mice, UF Researchers Find
Researchers at the University of Florida have discovered the combination of Lactoferrin, a protein found in cow and human milk, and diphenhydramine, an antihistamine used for allergy symptoms, increased resilience of mice towards the virus that causes COVID-19.
President’s Office Announces $10.9 Million for Third Round of Strategic Funding Awardees
UF President Ben Sasse announced a third round of strategic funding, which will see $10.9 million spread across 10 new projects aimed at solidifying UF's standing as a national research leader.
Combination of Two Common Compounds Improves COVID Survival in Mice, UF Researchers Find
UF researchers have discovered a combination of two over-the-counter compounds that may significantly improve the recovery of patients infected with COVID-19. Studies in mice have been successful, with the health of test subjects improving significantly or ending in full recovery.
UF Discovery Could Lead to Earlier Pancreatic Cancer Treatments
Pancreatic cancer’s stealth-like nature has the attention of University of Florida scientists, who have discovered a way to reverse a key cellular process involved in its progression.
Scientists Hone In on Treatment for Stimulant Use Disorder
University of Florida researchers have received a $19 million grant to tackle the growing problem of stimulant use disorder.
Sparian Biosciences Awarded $19 Million Five-Year NIH/ NIDA Grant to Fund Development of SBS-518 for Stimulant Use Disorder Through Phase 1 Clinical Development
Sparian Biosciences, Inc., a clinical-stage CNS-focused biopharmaceutical company, announced it has been awarded a $19 million, five-year grant to fund the development of SBS-518 from IND submission through Phase 1 clinical development.
Newly Discovered Probiotic Could Protect Caribbean Corals Threatened by Deadly, Devastating Disease
Researchers with the Smithsonian’s National Museum of Natural History and the University of Florida have discovered the first effective bacterial probiotic for treating and preventing stony coral tissue loss disease, or SCTLD, a mysterious ailment that has devastated Florida’s coral reefs since 2014 and is rapidly spreading throughout the Caribbean.
Targeting a Human Protein To Squash SARS-CoV-2 and Other Viruses
More than two years into the COVID-19 pandemic, people are realizing that the “new normal” will probably involve learning to co-exist with SARS-CoV-2. Some treatments are available, but with new variants emerging, researchers are looking toward new strategies. In ACS Infectious Diseases, scientists now report that apratoxin S4, an anticancer drug candidate that targets a human protein, can interfere with the replication of many viruses, including SARS-CoV-2 and influenza A, offering a possible pan-viral therapy.
